BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 22460456)

  • 1. Cardiac effects of osteostatin in mice.
    Meyer R; Schreckenberg R; Kraus D; Kretschmer F; Schulz R; Schlüter KD
    J Physiol Pharmacol; 2012 Feb; 63(1):17-22. PubMed ID: 22460456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Jak2 phosphorylation attenuates pressure overload cardiac hypertrophy.
    Beckles DL; Mascareno E; Siddiqui MA
    Vascul Pharmacol; 2006 Dec; 45(6):350-7. PubMed ID: 16822720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Src kinases mediate VEGFR2 transactivation by the osteostatin domain of PTHrP to modulate osteoblastic function.
    García-Martín A; Acitores A; Maycas M; Villanueva-Peñacarrillo ML; Esbrit P
    J Cell Biochem; 2013 Jun; 114(6):1404-13. PubMed ID: 23444047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 17beta-estradiol attenuates the development of pressure-overload hypertrophy.
    van Eickels M; Grohé C; Cleutjens JP; Janssen BJ; Wellens HJ; Doevendans PA
    Circulation; 2001 Sep; 104(12):1419-23. PubMed ID: 11560859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
    Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O
    J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Left ventricular accumulation of messenger ribonucleic acid coding for the natriuretic atrial factor in various experimental models of cardiac hypertrophy in rats].
    Urbain R; Michel JB; Bouveret P; Wisnewsky C; Schwartz K; Mercadier JJ
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1089-92. PubMed ID: 2530946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the osteoblastic activity conferred on Si-doped hydroxyapatite scaffolds by different osteostatin coatings.
    Manzano M; Lozano D; Arcos D; Portal-Núñez S; Orden CL; Esbrit P; Vallet-Regí M
    Acta Biomater; 2011 Oct; 7(10):3555-62. PubMed ID: 21693201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart.
    Tokudome T; Kishimoto I; Horio T; Arai Y; Schwenke DO; Hino J; Okano I; Kawano Y; Kohno M; Miyazato M; Nakao K; Kangawa K
    Circulation; 2008 May; 117(18):2329-39. PubMed ID: 18443239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin slows the progression of cardiac remodeling in mice with pressure overload and inhibits epidermal growth factor receptor activation.
    Liao Y; Zhao H; Ogai A; Kato H; Asakura M; Kim J; Asanuma H; Minamino T; Takashima S; Kitakaze M
    Hypertens Res; 2008 Feb; 31(2):335-44. PubMed ID: 18360054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis.
    Gao XM; Wong G; Wang B; Kiriazis H; Moore XL; Su YD; Dart A; Du XJ
    J Hypertens; 2006 Aug; 24(8):1663-70. PubMed ID: 16877971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular pressure overload during postnatal development. Effects on coronary vasodilator reserve and tolerance to hypothermic global ischemia.
    Yamamoto H; Avkiran M
    J Thorac Cardiovasc Surg; 1993 Jan; 105(1):120-31. PubMed ID: 8419692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure.
    Ohtani T; Mano T; Hikoso S; Sakata Y; Nishio M; Takeda Y; Otsu K; Miwa T; Masuyama T; Hori M; Yamamoto K
    J Hypertens; 2009 May; 27(5):1074-83. PubMed ID: 19349910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with N- and C-terminal peptides of parathyroid hormone-related protein partly compensate the skeletal abnormalities in IGF-I deficient mice.
    Rodríguez-de la Rosa L; López-Herradón A; Portal-Núñez S; Murillo-Cuesta S; Lozano D; Cediel R; Varela-Nieto I; Esbrit P
    PLoS One; 2014; 9(2):e87536. PubMed ID: 24503961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
    Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial natriuretic peptide behaviour and myocyte hypertrophic profile in combined pressure and volume-induced cardiac hypertrophy.
    Cavallero S; González GE; Puyó AM; Rosón MI; Pérez S; Morales C; Hertig CM; Gelpi RJ; Fernández BE
    J Hypertens; 2007 Sep; 25(9):1940-50. PubMed ID: 17762660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen protects against the development of salt-induced cardiac hypertrophy in heterozygous proANP gene-disrupted mice.
    Sangaralingham SJ; Tse MY; Pang SC
    J Endocrinol; 2007 Jul; 194(1):143-52. PubMed ID: 17592028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteostatin Inhibits Collagen-Induced Arthritis by Regulation of Immune Activation, Pro-Inflammatory Cytokines, and Osteoclastogenesis.
    Nácher-Juan J; Terencio MC; Alcaraz MJ; Ferrándiz ML
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31394717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon.
    Klein G; Schaefer A; Hilfiker-Kleiner D; Oppermann D; Shukla P; Quint A; Podewski E; Hilfiker A; Schröder F; Leitges M; Drexler H
    Circ Res; 2005 Apr; 96(7):748-55. PubMed ID: 15761199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.